Annual FCF
-$4.15 M
+$2.62 M+38.66%
December 1, 2023
Summary
- As of February 7, 2025, NBY annual free cash flow is -$4.15 million, with the most recent change of +$2.62 million (+38.66%) on December 1, 2023.
- During the last 3 years, NBY annual FCF has risen by +$597.00 thousand (+12.58%).
- NBY annual FCF is now -194.71% below its all-time high of $4.38 million, reached on December 31, 2006.
Performance
NBY Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$2.06 M
-$1.48 M-255.69%
September 1, 2024
Summary
- As of February 7, 2025, NBY quarterly free cash flow is -$2.06 million, with the most recent change of -$1.48 million (-255.69%) on September 1, 2024.
- Over the past year, NBY quarterly FCF has dropped by -$1.42 million (-218.86%).
- NBY quarterly FCF is now -180.52% below its all-time high of $2.56 million, reached on March 31, 2010.
Performance
NBY Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$4.81 M
-$1.42 M-41.70%
September 1, 2024
Summary
- As of February 7, 2025, NBY TTM free cash flow is -$4.81 million, with the most recent change of -$1.42 million (-41.70%) on September 1, 2024.
- Over the past year, NBY TTM FCF has dropped by -$48.00 thousand (-1.01%).
- NBY TTM FCF is now -363.67% below its all-time high of $1.82 million, reached on December 31, 2010.
Performance
NBY TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
NBY Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.7% | -218.9% | -1.0% |
| 3 y3 years | +12.6% | -20.8% | +18.3% |
| 5 y5 years | +26.1% | -20.8% | +18.3% |
NBY Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +55.1% | -255.7% | +52.3% | -41.7% | +51.3% |
| 5 y | 5-year | at high | +55.1% | -255.7% | +52.3% | -41.7% | +51.3% |
| alltime | all time | -194.7% | +77.8% | -180.5% | +62.0% | -363.7% | +74.8% |
NovaBay Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.06 M(+255.7%) | -$4.81 M(+41.7%) |
| Jun 2024 | - | -$580.00 K(-63.2%) | -$3.40 M(-24.9%) |
| Mar 2024 | - | -$1.57 M(+164.5%) | -$4.52 M(+9.0%) |
| Dec 2023 | -$4.15 M(-38.7%) | -$595.00 K(-8.0%) | -$4.15 M(-12.9%) |
| Sep 2023 | - | -$647.00 K(-62.1%) | -$4.76 M(-19.1%) |
| Jun 2023 | - | -$1.71 M(+42.3%) | -$5.89 M(+0.0%) |
| Mar 2023 | - | -$1.20 M(-0.7%) | -$5.88 M(-13.0%) |
| Dec 2022 | -$6.77 M(-26.8%) | -$1.21 M(-31.7%) | -$6.77 M(-31.5%) |
| Sep 2022 | - | -$1.77 M(+3.6%) | -$9.88 M(+3.0%) |
| Jun 2022 | - | -$1.71 M(-18.0%) | -$9.60 M(-2.9%) |
| Mar 2022 | - | -$2.08 M(-51.9%) | -$9.88 M(+6.9%) |
| Dec 2021 | -$9.24 M(+94.7%) | -$4.33 M(+191.3%) | -$9.24 M(+44.8%) |
| Sep 2021 | - | -$1.49 M(-25.3%) | -$6.38 M(+1.8%) |
| Jun 2021 | - | -$1.99 M(+37.7%) | -$6.27 M(+17.8%) |
| Mar 2021 | - | -$1.44 M(-1.5%) | -$5.33 M(+12.2%) |
| Dec 2020 | -$4.75 M(-40.3%) | -$1.47 M(+6.6%) | -$4.75 M(+0.8%) |
| Sep 2020 | - | -$1.38 M(+32.1%) | -$4.71 M(-2.6%) |
| Jun 2020 | - | -$1.04 M(+20.3%) | -$4.83 M(-13.3%) |
| Mar 2020 | - | -$865.00 K(-39.5%) | -$5.58 M(-29.8%) |
| Dec 2019 | -$7.95 M(+41.6%) | -$1.43 M(-4.7%) | -$7.95 M(-7.0%) |
| Sep 2019 | - | -$1.50 M(-15.9%) | -$8.54 M(-1.5%) |
| Jun 2019 | - | -$1.78 M(-44.9%) | -$8.67 M(+3.4%) |
| Mar 2019 | - | -$3.23 M(+59.8%) | -$8.38 M(+49.3%) |
| Dec 2018 | -$5.61 M(-13.8%) | -$2.02 M(+24.5%) | -$5.61 M(-14.1%) |
| Sep 2018 | - | -$1.63 M(+8.7%) | -$6.53 M(+39.1%) |
| Jun 2018 | - | -$1.50 M(+221.0%) | -$4.70 M(-4.5%) |
| Mar 2018 | - | -$466.00 K(-84.2%) | -$4.92 M(-24.5%) |
| Dec 2017 | -$6.51 M(-44.9%) | -$2.94 M(-1514.4%) | -$6.51 M(+68.1%) |
| Sep 2017 | - | $208.00 K(-112.1%) | -$3.87 M(-51.4%) |
| Jun 2017 | - | -$1.72 M(-16.9%) | -$7.97 M(-10.8%) |
| Mar 2017 | - | -$2.06 M(+583.8%) | -$8.94 M(-24.4%) |
| Dec 2016 | -$11.82 M(-36.7%) | -$302.00 K(-92.2%) | -$11.82 M(-26.5%) |
| Sep 2016 | - | -$3.89 M(+45.1%) | -$16.09 M(-1.7%) |
| Jun 2016 | - | -$2.68 M(-45.8%) | -$16.36 M(-14.4%) |
| Mar 2016 | - | -$4.95 M(+8.4%) | -$19.11 M(+2.3%) |
| Dec 2015 | -$18.68 M | -$4.57 M(+9.7%) | -$18.68 M(+2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | -$4.16 M(-23.4%) | -$18.26 M(+8.1%) |
| Jun 2015 | - | -$5.43 M(+20.2%) | -$16.89 M(+11.0%) |
| Mar 2015 | - | -$4.52 M(+9.1%) | -$15.22 M(+0.6%) |
| Dec 2014 | -$15.12 M(+15.4%) | -$4.14 M(+48.7%) | -$15.12 M(-4.0%) |
| Sep 2014 | - | -$2.79 M(-25.9%) | -$15.76 M(+2.5%) |
| Jun 2014 | - | -$3.76 M(-15.0%) | -$15.38 M(+11.2%) |
| Mar 2014 | - | -$4.43 M(-7.4%) | -$13.84 M(+5.5%) |
| Dec 2013 | -$13.11 M(+96.4%) | -$4.78 M(+98.3%) | -$13.11 M(+13.8%) |
| Sep 2013 | - | -$2.41 M(+8.7%) | -$11.52 M(+29.4%) |
| Jun 2013 | - | -$2.22 M(-40.1%) | -$8.90 M(+16.5%) |
| Mar 2013 | - | -$3.70 M(+16.0%) | -$7.64 M(+14.5%) |
| Dec 2012 | -$6.68 M(+104.7%) | -$3.19 M(-1633.7%) | -$6.68 M(+63.7%) |
| Sep 2012 | - | $208.00 K(-121.7%) | -$4.08 M(+16.4%) |
| Jun 2012 | - | -$958.00 K(-65.0%) | -$3.50 M(-40.6%) |
| Mar 2012 | - | -$2.74 M(+362.9%) | -$5.90 M(+80.8%) |
| Dec 2011 | -$3.26 M(-278.7%) | -$591.00 K(-175.7%) | -$3.26 M(+434.6%) |
| Sep 2011 | - | $781.00 K(-123.3%) | -$610.00 K(-63.7%) |
| Jun 2011 | - | -$3.35 M(+3216.8%) | -$1.68 M(+100.7%) |
| Mar 2011 | - | -$101.00 K(-104.9%) | -$838.00 K(-145.9%) |
| Dec 2010 | $1.82 M(-176.7%) | $2.06 M(-807.9%) | $1.82 M(-485.0%) |
| Sep 2010 | - | -$291.00 K(-88.4%) | -$474.00 K(-55.0%) |
| Jun 2010 | - | -$2.51 M(-197.8%) | -$1.05 M(+61.5%) |
| Mar 2010 | - | $2.56 M(-1172.0%) | -$652.00 K(-72.6%) |
| Dec 2009 | -$2.38 M(-77.5%) | -$239.00 K(-72.5%) | -$2.38 M(-53.7%) |
| Sep 2009 | - | -$870.00 K(-58.7%) | -$5.13 M(-15.1%) |
| Jun 2009 | - | -$2.10 M(-352.1%) | -$6.05 M(-18.3%) |
| Mar 2009 | - | $835.00 K(-127.9%) | -$7.40 M(-29.9%) |
| Dec 2008 | -$10.55 M(+52.2%) | -$2.99 M(+67.9%) | -$10.55 M(+0.4%) |
| Sep 2008 | - | -$1.78 M(-48.5%) | -$10.51 M(+8.1%) |
| Jun 2008 | - | -$3.46 M(+49.5%) | -$9.72 M(+12.5%) |
| Mar 2008 | - | -$2.31 M(-21.5%) | -$8.64 M(+24.6%) |
| Dec 2007 | -$6.93 M(-258.2%) | -$2.95 M(+196.0%) | -$6.93 M(+74.0%) |
| Sep 2007 | - | -$996.00 K(-58.2%) | -$3.99 M(+33.3%) |
| Jun 2007 | - | -$2.38 M(+292.6%) | -$2.99 M(+392.6%) |
| Mar 2007 | - | -$607.00 K | -$607.00 K |
| Dec 2006 | $4.38 M(-230.7%) | - | - |
| Dec 2005 | -$3.35 M | - | - |
FAQ
- What is NovaBay Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual FCF year-on-year change?
- What is NovaBay Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly FCF year-on-year change?
- What is NovaBay Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals TTM FCF year-on-year change?
What is NovaBay Pharmaceuticals annual free cash flow?
The current annual FCF of NBY is -$4.15 M
What is the all time high annual FCF for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual free cash flow is $4.38 M
What is NovaBay Pharmaceuticals annual FCF year-on-year change?
Over the past year, NBY annual free cash flow has changed by +$2.62 M (+38.66%)
What is NovaBay Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of NBY is -$2.06 M
What is the all time high quarterly FCF for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly free cash flow is $2.56 M
What is NovaBay Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, NBY quarterly free cash flow has changed by -$1.42 M (-218.86%)
What is NovaBay Pharmaceuticals TTM free cash flow?
The current TTM FCF of NBY is -$4.81 M
What is the all time high TTM FCF for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high TTM free cash flow is $1.82 M
What is NovaBay Pharmaceuticals TTM FCF year-on-year change?
Over the past year, NBY TTM free cash flow has changed by -$48.00 K (-1.01%)